Lyme Disease Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies | Valneva, Cortene, Blue Lake Biotechnology, Tarsus Pharmaceuticals, Inovio Pharmaceuticals, Aegis Life, Abzyme Therapeutics

DelveInsight's, "Lyme Disease Pipeline Insight 2025" report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Lyme Disease (LD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our comprehensive Lyme Disease Pipeline Report to stay informed about the latest advancements. Download copy now @ Lyme Disease Outlook- https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Lyme Disease Pipeline Report
• In March 2025, Pfizer announced a study is to understand if the study vaccine (called VLA15) is safe in healthy children. Lyme disease happens most often in children of this age. The study vaccine may be used potentially to help prevent Lyme disease. The goal of this study is to get more information about the safety of the study vaccine in this age group.
• In March 2025, ModernaTX, Inc. announced a phase 1/2, Randomized, Observer-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Immunogenicity of Heptavalent mRNA-1975 (SR1-7) and Monovalent mRNA-1982 (SR1) in Parallel Against Lyme Disease in Healthy Participants 18 Through 70 Years of Age.
• DelveInsight's Lyme Disease pipeline report depicts a robust space with 7+ active players working to develop 7+ pipeline therapies for Lyme Disease treatment.
• The leading Lyme Disease Companies such as Valneva, Cortene, Blue Lake Biotechnology, Tarsus Pharmaceuticals, Inovio Pharmaceuticals, Aegis Life, Abzyme Therapeutics, and others.
• Promising Lyme Disease Pipeline Therapies such as VLA15, mRNA-1975, Application of SHB001 and others.

Discover how the Lyme Disease treatment paradigm is evolving. Access DelveInsight's in-depth Lyme Disease Pipeline Analysis for a closer look at promising breakthroughs @ Lyme Disease Clinical Trials and Studies- https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Lyme Disease Emerging Drugs Profile
• VLA 15: Valneva
VLA15 is currently the only active vaccine program in clinical development against Lyme disease. VLA15 is a multivalent recombinant protein vaccine that targets six serotypes of Borrelia representing the most common pathogenic strains found in the United States and Europe. Valneva has completed recruitment and reported initial results for two Phase 2 clinical trials of VLA15 in over 800 healthy adults and in which Valneva observed high levels of antibodies against all six serotypes. Valneva announced a collaboration with Pfizer for late phase development and, if approved, commercialization of VLA15. As part of its collaboration with Pfizer, Valneva accelerated the pediatric development of VLA15 with an additional Phase 2 clinical trial initiated in March 2021. In July 2021, Pfizer and Valneva announced recruitment completion for VLA15-221 with a total of 625 participants, 5 to 65 years of age. The VLA15 program was granted Fast Track designation by the U.S. Food and Drug Administration (FDA) in July 2017

• CT38: Cortene
CT38 is a potent, short-lived, peptide agonist selective for CRFR2. It is comprised entirely of naturally-occurring amino acids. It was tested in animals and in healthy humans in a Phase 1 clinical trial. These studies have defined the safety profile of CT38 in humans and show that CT38 only lasts a few hours in the body.

The Lyme Disease Pipeline Report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Lyme Disease with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Lyme Disease Treatment.
• Lyme Disease Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Lyme Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Lyme Disease market.

Get a detailed analysis of the latest innovations in the Lyme Disease pipeline. Explore DelveInsight's expert-driven report today! @ Lyme Disease Unmet Needs- https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Lyme Disease Companies
Valneva, Cortene, Blue Lake Biotechnology, Tarsus Pharmaceuticals, Inovio Pharmaceuticals, Aegis Life, Abzyme Therapeutics, and others.

Lyme Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.

Lyme Disease Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Download DelveInsight's latest report to gain strategic insights into upcoming Lyme Disease Therapies and key Lyme Disease Developments @ Lyme Disease Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Lyme Disease Market Report
• Coverage- Global
• Lyme Disease Companies- Valneva, Cortene, Blue Lake Biotechnology, Tarsus Pharmaceuticals, Inovio Pharmaceuticals, Aegis Life, Abzyme Therapeutics, and others.
• Lyme Disease Pipeline Therapies- VLA15, mRNA-1975, Application of SHB001 and others.
• Lyme Disease Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Lyme Disease Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Which companies are leading the race in Lyme Disease drug development? Find out in DelveInsight's exclusive Lyme Disease Pipeline Report-access it now! @ Lyme Disease Emerging Drugs and Major Companies- https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Lyme Disease: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Lyme Disease - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. VLA 15: Valneva
9. Drug profiles in the detailed report.....
10. Early Stage Products (Phase I)
11. CT 38: Cortene
12. Drug profiles in the detailed report.....
13. Preclinical and Discovery Stage Products
14. Lyme disease vaccine - Introvacc
15. Drug profiles in the detailed report.....
16. Inactive Products
17. Lyme Disease Key Companies
18. Lyme Disease Key Products
19. Lyme Disease- Unmet Needs
20. Lyme Disease- Market Drivers and Barriers
21. Lyme Disease- Future Perspectives and Conclusion
22. Lyme Disease Analyst Views
23. Lyme Disease Key Companies
24. Appendix

List of Top Selling Market Research Reports in 2025

Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/report-store/intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.